Kornitzer Capital Management’s LeMaitre Vascular LMAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.18M Sell
12,298
-416
-3% -$42.7K 0.02% 407
2026
Q1
$1.39M Sell
12,714
-430
-3% -$41K 0.03% 345
2025
Q4
$1.07M Buy
13,144
+54
+0.4% +$4.65K 0.02% 394
2025
Q3
$1.15M Buy
13,090
+2,000
+18% +$179K 0.02% 385
2025
Q2
$921K Buy
+11,090
New +$927K 0.02% 400

Other funds holding LMAT

Kornitzer Capital Management's LMAT Position: Q2 2026 in Review

Kornitzer Capital Management reduced its LeMaitre Vascular (LMAT) stake by 3.3% in Q2 2026, selling an estimated $42.7K and leaving 12,298 shares worth $1.18M. The position accounts for 0.02% of the portfolio, ranked #407.

Kornitzer Capital Management first reported a position in LMAT in Q2 2025 and has held it in 5 quarters since. The position peaked at $1.39M in Q1 2026. 326 funds tracked by Wall St. Rank hold LMAT as of Q2 2026.

  • Kornitzer Capital Management held 12,298 shares of LeMaitre Vascular worth $1.18M as of Q2 2026.
  • Kornitzer Capital Management sold 416 LeMaitre Vascular shares in Q2 2026, an estimated $42.7K.
  • LeMaitre Vascular made up 0.02% of Kornitzer Capital Management's portfolio in Q2 2026, its #407 holding.
  • Kornitzer Capital Management first reported a position in LeMaitre Vascular in Q2 2025 and has held it in 5 quarters since.
  • Kornitzer Capital Management's LeMaitre Vascular position peaked at $1.39M in Q1 2026.
  • 326 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2026.

Based on Kornitzer Capital Management's 13F filing for Q2 2026, filed 31 Jul 2026.